155 related articles for article (PubMed ID: 7851587)
1. Elevated luteinizing hormone on the day of human chorionic gonadotropin administration does not reduce cycle fecundity in a low-dose flare-up in vitro fertilization protocol.
Lincoln SR; Long CA; Whitworth NS; Sopelak VM; Cowan BD
Fertil Steril; 1995 Mar; 63(3):563-5. PubMed ID: 7851587
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
Givens CR; Schriock ED; Dandekar PV; Martin MC
Fertil Steril; 1994 Nov; 62(5):1011-7. PubMed ID: 7926111
[TBL] [Abstract][Full Text] [Related]
3. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
Younis JS; Matilsky M; Radin O; Ben-Ami M
Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
[TBL] [Abstract][Full Text] [Related]
4. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
[TBL] [Abstract][Full Text] [Related]
5. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
6. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
7. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
[TBL] [Abstract][Full Text] [Related]
8. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle.
Hofmann GE; Bergh PA; Guzman I; Masuku S; Navot D
Hum Reprod; 1993 May; 8(5):695-8. PubMed ID: 8314961
[TBL] [Abstract][Full Text] [Related]
9. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
[TBL] [Abstract][Full Text] [Related]
10. Administration of human chorionic gonadotropin for in vitro fertilization-embryo transfer based on the serum luteinizing hormone (LH) concentration: the importance of synchronization with endogenous LH rises.
Jinno M; Ubukata Y; Hanyu I; Satou M; Yoshimura Y; Nakamura Y
Fertil Steril; 1995 Apr; 63(4):859-65. PubMed ID: 7890075
[TBL] [Abstract][Full Text] [Related]
11. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation.
Copperman AB; Horowitz GM; Kaplan P; Scott RT; Navot D; Hofmann GE
Fertil Steril; 1995 Jun; 63(6):1267-71. PubMed ID: 7750599
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
14. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist.
Bo-Abbas YY; Martin KA; Liberman RF; Cramer DW; Barbieri RL
Fertil Steril; 2001 Apr; 75(4):694-9. PubMed ID: 11287021
[TBL] [Abstract][Full Text] [Related]
15. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
16. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
Branigan EF; Estes MA
Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
[TBL] [Abstract][Full Text] [Related]
17. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
18. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
[TBL] [Abstract][Full Text] [Related]
19. Small increases in circulating luteinizing hormone (LH) concentrations shortly before human chorionic gonadotropin (hCG) are associated with reduced in vitro fertilization (IVF) pregnancy rate.
Munabi AK; King D; Bender S; Bustillo M; Dorfmann A; Schulman JD
J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):310-3. PubMed ID: 2127600
[TBL] [Abstract][Full Text] [Related]
20. Comparison between nafarelin and leuprolide acetate for in vitro fertilization: preliminary clinical study.
Dantas ZN; Vicino M; Balmaceda JP; Asch RH; Stone SC
Fertil Steril; 1994 Apr; 61(4):705-8. PubMed ID: 8150114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
